vs

Side-by-side financial comparison of PHOTRONICS INC (PLAB) and TANDEM DIABETES CARE INC (TNDM). Click either name above to swap in a different company.

TANDEM DIABETES CARE INC is the larger business by last-quarter revenue ($247.2M vs $210.4M, roughly 1.2× PHOTRONICS INC). PHOTRONICS INC runs the higher net margin — 10.9% vs -8.2%, a 19.1% gap on every dollar of revenue. On growth, TANDEM DIABETES CARE INC posted the faster year-over-year revenue change (5.5% vs -5.5%). Over the past eight quarters, TANDEM DIABETES CARE INC's revenue compounded faster (5.5% CAGR vs -3.8%).

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

PLAB vs TNDM — Head-to-Head

Bigger by revenue
TNDM
TNDM
1.2× larger
TNDM
$247.2M
$210.4M
PLAB
Growing faster (revenue YoY)
TNDM
TNDM
+11.0% gap
TNDM
5.5%
-5.5%
PLAB
Higher net margin
PLAB
PLAB
19.1% more per $
PLAB
10.9%
-8.2%
TNDM
Faster 2-yr revenue CAGR
TNDM
TNDM
Annualised
TNDM
5.5%
-3.8%
PLAB

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
PLAB
PLAB
TNDM
TNDM
Revenue
$210.4M
$247.2M
Net Profit
$22.9M
$-20.4M
Gross Margin
33.7%
55.3%
Operating Margin
22.9%
37.6%
Net Margin
10.9%
-8.2%
Revenue YoY
-5.5%
5.5%
Net Profit YoY
-32.4%
EPS (diluted)
$0.39
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLAB
PLAB
TNDM
TNDM
Q1 26
$247.2M
Q4 25
$290.4M
Q3 25
$210.4M
$249.3M
Q2 25
$211.0M
$240.7M
Q1 25
$212.1M
$234.4M
Q4 24
$222.6M
$282.6M
Q3 24
$211.0M
$244.0M
Q2 24
$217.0M
$221.9M
Net Profit
PLAB
PLAB
TNDM
TNDM
Q1 26
$-20.4M
Q4 25
$-589.0K
Q3 25
$22.9M
$-21.2M
Q2 25
$8.9M
$-52.4M
Q1 25
$42.9M
$-130.6M
Q4 24
$33.9M
$755.0K
Q3 24
$34.4M
$-23.3M
Q2 24
$36.3M
$-30.8M
Gross Margin
PLAB
PLAB
TNDM
TNDM
Q1 26
55.3%
Q4 25
57.7%
Q3 25
33.7%
53.9%
Q2 25
36.9%
52.3%
Q1 25
35.6%
50.5%
Q4 24
37.0%
55.7%
Q3 24
35.6%
51.1%
Q2 24
36.5%
50.8%
Operating Margin
PLAB
PLAB
TNDM
TNDM
Q1 26
37.6%
Q4 25
2.9%
Q3 25
22.9%
-9.2%
Q2 25
26.4%
-21.5%
Q1 25
24.6%
-51.6%
Q4 24
25.1%
-0.2%
Q3 24
24.7%
-10.7%
Q2 24
25.8%
-13.9%
Net Margin
PLAB
PLAB
TNDM
TNDM
Q1 26
-8.2%
Q4 25
-0.2%
Q3 25
10.9%
-8.5%
Q2 25
4.2%
-21.8%
Q1 25
20.2%
-55.7%
Q4 24
15.2%
0.3%
Q3 24
16.3%
-9.5%
Q2 24
16.7%
-13.9%
EPS (diluted)
PLAB
PLAB
TNDM
TNDM
Q1 26
$-0.30
Q4 25
$0.02
Q3 25
$0.39
$-0.31
Q2 25
$0.15
$-0.78
Q1 25
$0.68
$-1.97
Q4 24
$0.54
$0.00
Q3 24
$0.55
$-0.35
Q2 24
$0.58
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLAB
PLAB
TNDM
TNDM
Cash + ST InvestmentsLiquidity on hand
$575.8M
$570.3M
Total DebtLower is stronger
$16.0K
Stockholders' EquityBook value
$1.1B
$132.4M
Total Assets
$1.8B
$1.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLAB
PLAB
TNDM
TNDM
Q1 26
$570.3M
Q4 25
$292.7M
Q3 25
$575.8M
$319.1M
Q2 25
$558.4M
$315.4M
Q1 25
$642.2M
$368.6M
Q4 24
$640.7M
$438.3M
Q3 24
$606.4M
$473.3M
Q2 24
$559.9M
$452.4M
Total Debt
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
Q3 25
$16.0K
Q2 25
$19.0K
Q1 25
$21.0K
Q4 24
$25.0K
Q3 24
$28.0K
Q2 24
$2.5M
Stockholders' Equity
PLAB
PLAB
TNDM
TNDM
Q1 26
$132.4M
Q4 25
$155.2M
Q3 25
$1.1B
$133.0M
Q2 25
$1.1B
$133.3M
Q1 25
$1.1B
$155.3M
Q4 24
$1.1B
$263.1M
Q3 24
$1.1B
$237.7M
Q2 24
$1.0B
$233.9M
Total Assets
PLAB
PLAB
TNDM
TNDM
Q1 26
$1.2B
Q4 25
$881.1M
Q3 25
$1.8B
$874.7M
Q2 25
$1.7B
$875.7M
Q1 25
$1.7B
$922.1M
Q4 24
$1.7B
$967.7M
Q3 24
$1.6B
$957.7M
Q2 24
$1.6B
$937.5M
Debt / Equity
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLAB
PLAB
TNDM
TNDM
Operating Cash FlowLast quarter
$50.1M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
11.8%
2.5%
Cash ConversionOCF / Net Profit
2.19×
TTM Free Cash FlowTrailing 4 quarters
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
$9.8M
Q3 25
$50.1M
$8.3M
Q2 25
$31.5M
$-9.5M
Q1 25
$78.5M
$-18.3M
Q4 24
$68.4M
$10.7M
Q3 24
$75.1M
$26.8M
Q2 24
$76.5M
$-5.3M
Free Cash Flow
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
$3.1M
Q3 25
$25.2M
$4.2M
Q2 25
$-29.1M
$-15.7M
Q1 25
$43.3M
$-21.2M
Q4 24
$25.2M
$7.6M
Q3 24
$50.7M
$21.5M
Q2 24
$56.5M
$-11.7M
FCF Margin
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
1.1%
Q3 25
12.0%
1.7%
Q2 25
-13.8%
-6.5%
Q1 25
20.4%
-9.1%
Q4 24
11.3%
2.7%
Q3 24
24.0%
8.8%
Q2 24
26.0%
-5.3%
Capex Intensity
PLAB
PLAB
TNDM
TNDM
Q1 26
2.5%
Q4 25
2.3%
Q3 25
11.8%
1.6%
Q2 25
28.7%
2.6%
Q1 25
16.6%
1.3%
Q4 24
19.4%
1.1%
Q3 24
11.6%
2.1%
Q2 24
9.2%
2.9%
Cash Conversion
PLAB
PLAB
TNDM
TNDM
Q1 26
Q4 25
Q3 25
2.19×
Q2 25
3.55×
Q1 25
1.83×
Q4 24
2.02×
14.19×
Q3 24
2.18×
Q2 24
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

TNDM
TNDM

Segment breakdown not available.

Related Comparisons